Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.28
-0.88 (-4.16%)
At close: Dec 5, 2025, 4:00 PM EST
20.26
-0.02 (-0.10%)
After-hours: Dec 5, 2025, 5:01 PM EST
Neurogene Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Neurogene stock have an average target of 38.5, with a low estimate of 16 and a high estimate of 70. The average target predicts an increase of 89.84% from the current stock price of 20.28.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Neurogene stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $65 → $70 | Strong Buy | Maintains | $65 → $70 | +245.17% | Nov 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $65 | Strong Buy | Maintains | $45 → $65 | +220.51% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +121.89% | Oct 9, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +146.55% | Jun 17, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $22 → $26 | Buy | Maintains | $22 → $26 | +28.21% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
n/a
from 925.00K
Revenue Next Year
n/a
EPS This Year
-4.28
from -4.28
EPS Next Year
-5.31
from -4.28
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -4.33 | -4.56 | |
| Avg | -4.28 | -5.31 | |
| Low | -4.18 | -6.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.